JoelMKremerMDMACR, FACP
Rheumatology • Albany, NYRheumatoid Arthritis & Related
Pfaff Family Professor of Medicine, Albany Medical College,Director of Research, The Center for Rheumatology
Dr. Kremer is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
4 Tower Pl
8TH floor
Albany, NY 12203Phone+1 518-489-4471Fax+1 518-489-4506
Education & Training
Albany Medical CenterFellowship, Rheumatology, 1977 - 1979- Albany Medical CenterResidency, Internal Medicine, 1974 - 1977
Lewis Katz School of Medicine at Temple UniversityClass of 1974
Certifications & Licensure
NY State Medical License 1975 - 2027- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Rheumatology
Awards, Honors, & Recognition
- Meaningful Use Stage 1 Certification Centers for Medicare & Medicaid Services, 2012
- Alpha Omega Alpha
- Engalitcheff Award of the Arthritis Foundation
- Join now to see all
Clinical Trials
- A Phase 2 Study to Evaluate the Safety, Tolerability, and Activity of Fontolizumab in Subjects With Active Rheumatoid Arthritis Start of enrollment: 2005 Dec 01
- The CORRONA Treat to Target Trial: Outcomes and Feasibility in a US Population Start of enrollment: 2011 Jul 01
- An Extension Study in Participants With Moderate to Severe Rheumatoid Arthritis Start of enrollment: 2013 Jun 27
- Join now to see all
Publications & Presentations
PubMed
- Disease response in rheumatoid arthritis across four biologic therapies associates with improvement in paraoxonase-1 activity and oxylipins.Amir A Razmjou, Joel M Kremer, Dimitrios A Pappas, Jeffrey R Curtis, Jennifer Wang
RMD Open. 2024-10-26 - Metabolic Syndrome, Adipokines, and Response to Advanced Therapies in Rheumatoid Arthritis.Joshua F Baker, George Reed, Ted R Mikuls, Geoffrey M Thiele, Dimitrios A Pappas
Arthritis & Rheumatology. 2024-10-17 - Effect of biologic agents and inflammation on lipid levels and cardiovascular risk in rheumatoid arthritis patients.Dimitrios A Pappas, George Reed, Kevin Kane, Jeffrey R Curtis, Christina Charles-Schoeman
Seminars in Arthritis and Rheumatism. 2024-10-01
Other
- Hepatotoxicity associated with chronic oral methotrexate for nonmalignant diseaseKremer JM
http://www.uptodate.com/contents/hepatotoxicity-associated-with-chronic-oral-methotrexate-for-nonmal
UpToDate, Wolters Kluwer Health - 2013-04-12 - Major side effects of low-dose methotrexateKremer JM
http://www.uptodate.com/contents/major-side-effects-of-low-dose-methotrexate
UpToDate, Wolters Kluwer Health - 2012-12-18 - Use of methotrexate in the treatment of rheumatoid arthritisKremer JM
http://www.uptodate.com/contents/use-of-methotrexate-in-the-treatment-of-rheumatoid-arthritis
UpToDate, Wolters Kluwer Health - 2012-05-04
Authored Content
- In Memoriam: Remembering William R. Palmer, MDAugust 2021
Press Mentions
- In Memoriam: Remembering William R. Palmer, MDAugust 24th, 2021
Extensive Assessment Critical to Dispel 'Ambiguity' Mimics in Juvenile DermatomyositisAugust 6th, 2021
Disease Activity and Patient-Reported Outcomes in Patients with Rheumatoid Arthritis and Sjögren’s Syndrome Enrolled in a Large Observational US RegistryMay 24th, 2020- Join now to see all
Professional Memberships
- Fellow
- Master Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
